PL431613A1 - Związek do zastosowania jako lek, inhibitor kinazy PERK oraz jego zastosowanie do zapobiegania i leczenia chorób neurodegeneracyjnych zależnych od stresu retikulum endoplazmatycznego - Google Patents
Związek do zastosowania jako lek, inhibitor kinazy PERK oraz jego zastosowanie do zapobiegania i leczenia chorób neurodegeneracyjnych zależnych od stresu retikulum endoplazmatycznegoInfo
- Publication number
- PL431613A1 PL431613A1 PL431613A PL43161319A PL431613A1 PL 431613 A1 PL431613 A1 PL 431613A1 PL 431613 A PL431613 A PL 431613A PL 43161319 A PL43161319 A PL 43161319A PL 431613 A1 PL431613 A1 PL 431613A1
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- compound
- prevention
- kinase inhibitor
- endoplasmic reticulum
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 108010089429 PERK kinase Proteins 0.000 title abstract 2
- 230000001419 dependent effect Effects 0.000 title abstract 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 title abstract 2
- 229940043355 kinase inhibitor Drugs 0.000 title abstract 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Przedmiotem wynalazku jest związek o wzorze ogólnym I, do zastosowania jako lek, związek do zastosowania jako inhibitor kinazy PERK do zapobiegania i leczenia chorób zależnych od stresu retikulum endoplazmatycznego. Korzystnie wspomniane choroby są wybrane z grupy obejmującej jaskrę, chorobę Alzheimera, chorobę Parkinsona.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL431613A PL241218B1 (pl) | 2019-10-25 | 2019-10-25 | Związek do zastosowania w zapobieganiu i/lub leczeniu chorób neurodegeneracyjnych zależnych od stresu retikulum endoplazmatycznego |
| EP20204016.8A EP3815682A1 (en) | 2019-10-25 | 2020-10-27 | A perk kinase inhibitor for treating diseases associated with endoplasmic reticulum stress |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL431613A PL241218B1 (pl) | 2019-10-25 | 2019-10-25 | Związek do zastosowania w zapobieganiu i/lub leczeniu chorób neurodegeneracyjnych zależnych od stresu retikulum endoplazmatycznego |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL431613A1 true PL431613A1 (pl) | 2021-05-04 |
| PL241218B1 PL241218B1 (pl) | 2022-08-22 |
Family
ID=73646059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL431613A PL241218B1 (pl) | 2019-10-25 | 2019-10-25 | Związek do zastosowania w zapobieganiu i/lub leczeniu chorób neurodegeneracyjnych zależnych od stresu retikulum endoplazmatycznego |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3815682A1 (pl) |
| PL (1) | PL241218B1 (pl) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010014253A2 (en) | 2008-08-01 | 2010-02-04 | University Of Florida Research Foundation, Inc. | Ant4 inhibitor compounds and methods of use thereof |
-
2019
- 2019-10-25 PL PL431613A patent/PL241218B1/pl unknown
-
2020
- 2020-10-27 EP EP20204016.8A patent/EP3815682A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL241218B1 (pl) | 2022-08-22 |
| EP3815682A1 (en) | 2021-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021000382A1 (es) | Compuestos novedosos de sulfonamidaurea | |
| CO2020015176A2 (es) | Compuestos novedosos | |
| GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
| SA520412278B1 (ar) | مركبات ومشتقات بيريدو بيريمينون بها استبدال ببنزيل أمينو جديدة كمثبطات جين أس أوه أس 1 | |
| SA521422143B1 (ar) | 15-pgdh مثبط | |
| UY38425A (es) | Procesos novedosos para preparar n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1- isopropil-1h-pirazol-3-sulfonamida y sales de éste | |
| GEP20257731B (en) | Substituted aminothiazoles as dgkzeta inhibitors for immune activation | |
| MX2020000261A (es) | Nuevos compuestos. | |
| UY38186A (es) | Sal sódica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1-isopropil-1h-pirazol-3-sulfonamida | |
| MX2021007432A (es) | Compuestos y composiciones para inhibir la actividad de shp2. | |
| MX2020006460A (es) | Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar. | |
| SA520412335B1 (ar) | مشتقات أوكسي فلورو ببريدين كمثبط كيناز | |
| TN2020000125A1 (en) | Amino-fluoropiperidine derivative as kinase inhibitor | |
| JOP20190193A1 (ar) | ممركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان | |
| EP4344743A3 (en) | Heterocyclic flavone derivatives, compositions, and methods related thereto | |
| WO2007022380A3 (en) | Bis-aryl amide compounds and methods of use | |
| MY196572A (en) | Amino-Methyl Piperidine Derivative as Kinase Inhibitor | |
| DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
| WO2018153508A3 (en) | INHIBITORS OF SULFOXIMINE GLYCOSIDASE | |
| CL2021003455A1 (es) | Análogos de 3-(5-meti l-1 ,3-tiazol-2-1 l)-n--{( 1 r)-1-[2-(trifluoro-metil)pirimidin-5-il]etil}benzamida | |
| EA201001586A1 (ru) | Соединения и композиции в качестве ингибиторов itpkb | |
| MY197561A (en) | Composition for increasing expression of pgc-1? | |
| MY202753A (en) | Griseofulvin compound and pharmaceutical use thereof | |
| MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
| BR112021011325A2 (pt) | Derivados de rapamicina |